Detecting mutations in single cells from cancer specimens is now a major area of translational research. In a recent article in this journal, Khalique et al validated an immunohistochemistry assay for ARID1A that reliably identifies loss of function mutations in single cells in tissue sections. This work exemplifies best practice for developing and orthogonally validating immunohistochemical assays to provide clearly interpretable mutational results with spatial context
In routine cancer molecular pathology, various independent experiments are required to determine mut...
Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most ...
Most mutation detection techniques are unsuitable for routine use on solid tumours. Important parame...
It would be advantageous to measure mutation load in situ in order to determine the relationship bet...
ARID1A is a tumour suppressor gene that is frequently mutated in clear cell and endometrioid carcino...
The human body is composed of trillions of cells closely working together to maintain a functional o...
Only a few studies have demonstrated successful molecular analysis after whole genome amplification ...
AbstractIdentification of biomarkers for positive and negative predictors of response to cancer ther...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
Abstract Even within a single type of cancer, cells of various types exist and play interrelated rol...
<div><p>Somatic mutations identified on genes related to the cancer-developing signaling pathways ha...
Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn...
ARID1A is a known suppressor of tumour formation and the Human Protein Atlas antibody HPA005456 has ...
ARID1A is a known suppressor of tumour formation and the Human Protein Atlas antibody HPA005456 has ...
In routine cancer molecular pathology, various independent experiments are required to determine mut...
Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most ...
Most mutation detection techniques are unsuitable for routine use on solid tumours. Important parame...
It would be advantageous to measure mutation load in situ in order to determine the relationship bet...
ARID1A is a tumour suppressor gene that is frequently mutated in clear cell and endometrioid carcino...
The human body is composed of trillions of cells closely working together to maintain a functional o...
Only a few studies have demonstrated successful molecular analysis after whole genome amplification ...
AbstractIdentification of biomarkers for positive and negative predictors of response to cancer ther...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
Abstract Even within a single type of cancer, cells of various types exist and play interrelated rol...
<div><p>Somatic mutations identified on genes related to the cancer-developing signaling pathways ha...
Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn...
ARID1A is a known suppressor of tumour formation and the Human Protein Atlas antibody HPA005456 has ...
ARID1A is a known suppressor of tumour formation and the Human Protein Atlas antibody HPA005456 has ...
In routine cancer molecular pathology, various independent experiments are required to determine mut...
Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most ...
Most mutation detection techniques are unsuitable for routine use on solid tumours. Important parame...